Wang Lai — SEC Form 4 filings
SEC reporting owner CIK 1852291. 19 Form 4 filings on record with FilingPulse; latest filed 2026-06-25.
Transaction summary — filings shown
Covers all 19 filings on record, filed 2024-06-07 to 2026-06-25. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 32 legs across 14 filings — 31,842 shares, $8,412,012 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 10.
- Largest priced transaction: sale of 5,000 shares @ $350.06 ($1,750,312) in BeOne Medicines Ltd., filed 2025-09-11.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| BeOne Medicines Ltd. (ONC) | President, Global Head of R&D | 19 | — | 32 legs · 31,842 sh · $8,412,012 | 10 |
Form 4 filings — Wang Lai
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-25 | 4 | BeOne Medicines Ltd. (ONC) | Sale (S): 1,068 @ $276.74 | EDGAR |
| 2026-06-18 | 4 | BeOne Medicines Ltd. (ONC) | Sale (S): 1,169 @ $265.39 | EDGAR |
| 2026-06-15 | 4 | BeOne Medicines Ltd. (ONC) | Grant/award (A): 118,625 @ $0 · Sale (S): 756 @ $261.00 · Grant/award (A): 229,775 (derivative) @ $0 | EDGAR |
| 2026-06-10 | 4 | BeOne Medicines Ltd. (ONC) | Sale (S): 1,327 @ $269.34 · Sale (S): 40 @ $270.73 | EDGAR |
| 2026-03-10 | 4 | BeOne Medicines Ltd. (ONC) | Grant/award (A): 112,606 @ $0 · Grant/award (A): 55,029 @ $0 | EDGAR |
| 2026-01-05 | 4 | BeOne Medicines Ltd. (ONC) | Grant/award (A): 427,895 @ $0 | EDGAR |
| 2025-09-11 | 4 | BeOne Medicines Ltd. (ONC) | Sale (S): 5,000 @ $350.06 | EDGAR |
| 2025-07-31 | 4 | BeOne Medicines Ltd. (ONC) | Sale (S): 2,949 @ $302.00 · Sale (S): 292 @ $302.92 · Sale (S): 800 @ $304.16 · Sale (S): 259 @ $305 | EDGAR |
| 2025-07-22 | 4 | BeOne Medicines Ltd. (ONC) | Sale (S): 700 @ $300 | EDGAR |
| 2025-06-25 | 4 | BeOne Medicines Ltd. (ONC) | Sale (S): 1,028 @ $260 | EDGAR |
| 2025-06-18 | 4 | BeOne Medicines Ltd. (ONC) | Sale (S): 1,177 @ $266.40 · Sale (S): 470 @ $251.37 | EDGAR |
| 2025-06-12 | 4 | BeOne Medicines Ltd. (ONC) | Grant/award (A): 86,359 @ $0 · Grant/award (A): 162,565 (derivative) @ $0 | EDGAR |
| 2025-06-10 | 4 | BeOne Medicines Ltd. (ONC) | Sale (S): 600 @ $250.71 · Sale (S): 202 @ $251.89 · Sale (S): 300 @ $253.19 · Sale (S): 300 @ $255.30 | EDGAR |
| 2025-03-07 | 4 | BeiGene, Ltd. (BGNE) | Grant/award (A): 69,251 @ $0 | EDGAR |
| 2025-02-25 | 4 | BeiGene, Ltd. (BGNE) | Sale (S): 1,327 @ $254.82 · Sale (S): 575 @ $255.86 · Sale (S): 479 @ $256.70 · Sale (S): 437 @ $258.18 · Sale (S): 1,782 @ $258.73 · Sale (S): 400 @ $260.17 | EDGAR |
| 2024-10-01 | 4 | BeiGene, Ltd. (BGNE) | Sale (S): 5,000 @ $220.35 | EDGAR |
| 2024-06-26 | 4 | BeiGene, Ltd. (BGNE) | Sale (S): 1,062 @ $159.80 · Sale (S): 2 @ $161.10 | EDGAR |
| 2024-06-20 | 4 | BeiGene, Ltd. (BGNE) | Sale (S): 237 @ $158.50 · Sale (S): 478 @ $159.00 · Sale (S): 485 @ $159.42 · Sale (S): 300 @ $159.90 · Sale (S): 841 @ $153.75 | EDGAR |
| 2024-06-07 | 4 | BeiGene, Ltd. (BGNE) | Grant/award (A): 168,935 @ $0 · Grant/award (A): 318,253 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1852291 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →